Loading clinical trials...
Loading clinical trials...
Remotely Monitored Rehabilitation in Hemato-oncological Survivors After Treatment: The Tele@Home Study
This study investigates whether the 12-week home-based exercise training with remote guidance and telemonitoring compared to regular center-based training leads to better long-term cardiorespiratory fitness and physical activity levels in post-treatment patients with lymphoma.
80 lymphoma cancer patients post-treatment (except adjuvant treatment) will be enrolled in the study. Cardiorespiratory fitness (peak oxygen consumption), adverse events, body composition, quality of life, costs and adherence to exercise prescription will be evaluated at baseline, 12-week, and year after enrollment. Investigators assume that home-based training with remote guidance and telemonitoring with objective training data obtained during rehabilitation after cancer treatment will improve long-term motivation and effectiveness of independent training in cancer survivors, resulting in superior cardiorespiratory fitness and physical activity levels.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital Brno
Brno, Czechia
Start Date
April 1, 2023
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2026
Last Updated
September 29, 2025
80
ESTIMATED participants
Home-based training
DEVICE
Center-based training
DEVICE
Lead Sponsor
Brno University Hospital
NCT06337318
NCT07388563
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions